Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
RCUS
$29.48
+2.15%
RCUS · Arcus Biosciences, Inc.
$29.48
+0.62 (+2.15%)
At close · Aug 14
Market Cap
$3.75B
Shares
127.33M
All earnings calls
Earnings call · FY2024 Q2
Arcus Biosciences, Inc. Q2 FY2024 Earnings Call
Arcus Biosciences, Inc. Q2 FY2024 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$39.00M
+34.5% YoY
Diluted EPS
-$1.02
Net income
-$93.00M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 8, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 8, 2024 · complete as-filed document